ArticleFrontiers in pediatrics2025
A Chinese premature infant with cleidocranial dysplasia characterized by heterozygous RUNX2 mutation and cerebral infarction: a case report.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Cleidocranial dysplasia (CCD) is a rare genetic skeletal disorder with a low incidence rate. This study reports the first documented case in Inner Mongolia, involving a premature male newborn with a history of birth asphyxia and cerebral infarction. The patient exhibited characteristic clinical features, including abnormal cranial suture palpation, hypertelorism, depressed nasal bridge, and shortened limbs, leading to genetic testing that identified a heterozygous mutation in the RUNX2 gene-the known cause of CCD. Methods: Clinical examination included detailed physical assessment, cranial MRI, CT scan with 3D reconstruction, and chest X-ray. Genetic analysis was performed to detect mutations in the RUNX2 gene. Imaging results revealed significantly widened cranial sutures, open fontanelles, partial skull defects, right clavicular hypoplasia, and reduced bone density. Conclusion: Genetic testing confirmed a heterozygous pathogenic variant in the RUNX2 gene, consistent with a diagnosis of cleidocranial dysplasia. This case represents the first reported instance of CCD in Inner Mongolia. Discussion: This case underscores the importance of recognizing the clinical and genetic features of RUNX2-related CCD to facilitate early and accurate diagnosis. The findings aim to enhance clinical awareness of this rare condition, particularly in regions where it has not been previously reported, and to promote timely intervention and genetic counseling.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.